Biomerics LLC, a contract manufacturer for the interventional medical device market, and ATL Technology LLC have mutually agreed to dissolve their joint venture, Biomerics ATL LLC, the companies reported in a news release. Biomerics has purchased ATL Technology’s interests in the joint venture and will rename the business unit Biomerics CRI (BCRI), bringing its operations up to seven business units with more than 1300 employees.
The joint venture had begun in 2018 with the acquisition of assets from Catheter Research Inc. (CRI Medical) and its facilities in Indiana and Costa Rica. CRI had served the medical device fluid management market. Biomerics's purchase of ATL’s ownership will enable it to expand its presence into Costa Rica and its relationship with these customers. It will also increase the company's capabilities, including extrusion, injection molding, high-volume cleanroom assembly, kitting, and packaging services.
“Our expansion of operations in Costa Rica is strategic,” stated Travis Sessions, CEO of Biomerics, in a news release. “We see great potential in these assets providing high volume assembly operations. We recently expanded the facility with a new 3,700-sq-ft cleanroom and are planning an additional 20,000-sq-ft expansion in 2021.”
Added Craig England, who now serves as the new business unit’s president: “It has been an honor working with both Biomerics and ATL Technology over the last 18 months. The new strategy will add to the momentum of the organization and prepare us for great things down the road as we unlock the synergies of Biomerics.”
Anthony Amador is now general manager of the Costa Rica facility. All employees have been retained as part of the realignment and will continue operations as usual under the new business entity, it was reported in the release.
Biomerics has ISO-13485:2016 compliant operations in Minnesota, Utah, Texas, Connecticut, Indiana, and Costa Rica.
[Image courtesy of BIOMERICS]